Evidence map›Paper›PMID 28681073›Full record

ArticleInternational journal of colorectal disease2017

γ-Catenin acts as a tumor suppressor through context-dependent mechanisms in colorectal cancer.

Jutta Maria Nagel, Harald Lahm, Andrea Ofner, Burkhard Göke, Frank Thomas Kolligs

Abstract readComparative Study
PubMed Publisher
In one paragraph

Article in International journal of colorectal disease, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact, top 94% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Jutta Maria NagelDepartment of Medicine II, University Hospital, LMU Munich, Marchioninistr. 15, 81377, Munich, Germany. Jutta.Nagel@med.uni-muenchen.de.
Harald LahmInstitute of Molecular Animal Breeding and Biotechnology, Gene Center, Ludwig-Maximilian University of Munich (LMU), Feodor-Lynen-Strasse 25, 81377, Munich, Germany.
Andrea OfnerDepartment of Medicine II, University Hospital, LMU Munich, Marchioninistr. 15, 81377, Munich, Germany.
Burkhard GökeDepartment of Medicine II, University Hospital, LMU Munich, Marchioninistr. 15, 81377, Munich, Germany.
Frank Thomas KolligsDepartment of Medicine II, University Hospital, LMU Munich, Marchioninistr. 15, 81377, Munich, Germany.
Ludwig-Maximilians-Universität München · DELMU Klinikum · DE

Funding

Deutsche Forschungsgemeinschaft (DE) GO417/4-1 (KFO128)Deutsche Forschungsgemeinschaft (DE) KO1826/3-1 (KFO128)
6 · The paper itself

Abstract

purposeγ-Catenin is a protein closely related to β-catenin. While the overexpression of β-catenin has been linked with impaired prognosis and survival in various malignancies, both oncogenic and tumor suppressor functions have been described for γ-catenin. Thus, its role in cancer remains controversial. In this study, we examined the impact of γ-catenin expression on the malignant potential of colorectal cancer cells.

methodsγ-Catenin was knocked down by short interfering RNA in the γ-catenin-proficient DLD-1 cell line and stably overexpressed in the γ-catenin-deficient cell line RKO. The effects of these molecular manipulations on the malignant potential of the cell lines were tested in vitro and in vivo in a xenograft tumor model.

resultsγ-Catenin contributed to Wnt signaling independent of the cellular context. Unlike its sister molecule β-catenin, γ-catenin inhibited cellular invasion and anoikis in cells endogenously expressing γ-catenin. In line with this tumor suppressor function, its de novo expression in RKO cells inhibited proliferation via cell cycle arrest. In a xenograft tumor model, overexpression of γ-catenin starkly reduced tumor growth in vivo.

conclusionsThis is the first report demonstrating a tumor-suppressive effect of γ-catenin in colorectal cancer both in vitro and in vivo. Detailed in vitro analysis revealed that effects of γ-catenin differ in γ-catenin proficient and deficient cells, indicating that its function in colorectal cancer is dependent on the cellular context. This finding adds to our understanding of γ-catenin and may have implications for future studies of catenin/Wnt targeted cancer therapies.

Indexed as

AnimalsAnoikisbeta CateninCell Cycle CheckpointsCell MovementCell ProliferationColorectal NeoplasmsFemalegamma CateninGene Expression Regulation, NeoplasticGene Knockdown TechniquesHCT116 CellsHT29 CellsHumansMice, NudeRNA Interferencebeta CateninCTNNB1 protein, humangamma CateninJUP protein, humanTumor Suppressor ProteinsColorectal cancerWnt signalingγ-Catenin

Identifiers

PMID28681073
OpenAlexW2733666383

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.